• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Indonesia·Healthcare·OMED.JK
Share

PT Jayamas Medica Industri Tbk Stocks

IDR 226Last Updated 07.08.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

IDR 353.27M

IDR 226
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Operating under its OneMed brand, PT Jayamas Medica Industri Tbk specializes in the production and distribution of a diverse array of medical devices and supplies. The company's reach extends across Indonesia, Asia, the United States, South America, and Africa. Its business operations are structured into three primary segments: manufacturing, distribution, and retail. The extensive product portfolio includes a comprehensive selection of disposable and consumable medical items, such as syringes, gauze, plaster bandages, masks, medical gloves, urine bags, foley catheters, and alcoholic tissues. Additionally, it provides various antiseptic and disinfectant solutions, including povidone iodine, medical alcohol, and blood cleansing liquids like Hdsol. Diagnostic instruments and equipment form another key category, offering everything from patient monitors, vital signs monitors, and ECG readers to syringe pumps, infusion pumps, tensimeters, and oxymeters. For mobility and rehabilitation, the company supplies products like wheelchairs, crutches, and walkers. Its biotechnology and laboratory offerings encompass pregnancy tests, PCR tests, blood collection tubes, PCT tubes, and chemical reagents. Rounding out its inventory are hospital furnishings, such as patient beds, bedside cabinets, pediatric patient beds, and surgical lamps, alongside other general consumer medical products. These essential medical goods are distributed and retailed through the company's network of Medicom stores and various digital platforms. PT Jayamas Medica Industri Tbk was founded in Sidoarjo, Indonesia, in 2000 and functions as a subsidiary of Pt. Intisumber Hasilsempurna.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of OMED.JK is 281 and suggests 24.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

08.08.2026 13:01

A Hot Topic from SpaceX, Burry’s Bleak Outlook, and a Touching “Startup” Born Out of Necessity

08.08.2026 12:15

Ukraine has promised the U.S. not to attack the CPC infrastructure in the Black Sea — Bloomberg

08.08.2026 03:20

Billionaire Ekman Identified the Main Risk for Investors in the Anthropic and OpenAI IPOs

08.08.2026 02:52

U.S. stocks posted their best weekly gain since mid-April. The S&P 500 hit a new record high.

08.08.2026 02:36

OpenAI has suspended development of a new AI model due to cybersecurity risks

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026